David Collingridge

May 9, 2024 | thelancet.com | David Collingridge

Speaking on behalf of researchers from 25 Spanish centres, Felipe Couñago (GenesisCare, Madrid, Spain) reported that moderate postoperative hypofractionated radiotherapy for patients with prostate cancer yields a good biochemical response, quality of life, and limited gastrointestinal and genitourinary toxicity. The non-randomised HYPORT-ES phase 2 trial recruited 407 patients and delivered 62·5 Gy in 2·5 Gy fractions via intensity-modulated radiotherapy or image-guided radiotherapy.

Nov 1, 2023 | thelancet.com | Allison Landman |David Collingridge

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Nov 1, 2023 | thelancet.com | Allison Landman |David Collingridge

In 2015, three reports on global surgery were published. Each had the goal of improving the surgical landscape by outlining changes needed to ensure the provision of, and access to, high-quality, safe, and timely surgery worldwide. These reports by The Lancet, 1 Meara JG Leather AJM Hagander L et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. The Lancet Oncology, 2 Sullivan R Alatise OI Anderson BO et al.

Dec 14, 2022 | thelancet.com | David Collingridge

Nov 15, 2022 | thelancet.com | Márcia Costa |David Collingridge